JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB218106

Anti-uPA Receptor/U-PAR antibody [EPR20191]

Be the first to review this product! Submit a review

|

(8 Publications)

Rabbit Recombinant Monoclonal uPA Receptor/U-PAR antibody. Suitable for WB, IHC-P and reacts with Human samples. Cited in 8 publications.

View Alternative Names

CD87, MO3, UPAR, PLAUR, Urokinase plasminogen activator surface receptor, U-PAR, uPAR, Monocyte activation antigen Mo3

5 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-uPA Receptor/U-PAR antibody [EPR20191] (AB218106)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-uPA Receptor/U-PAR antibody [EPR20191] (AB218106)

Immunohistochemical analysis of paraffin-embedded human ovarian cancer tissue labeling uPA Receptor/U-PAR with ab218106 at 1/500 dilution followed by Goat Anti-Rabbit IgG H&L (HRP) Ready to use.

Membranous staining on dissociative cancer cells in blood vessel of human ovarian cancer is observed [PMID : 25120753].

Counter stained with Hematoxylin.

Secondary antibody only control : Used PBS instead of primary antibody secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) Ready to use.

Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-uPA Receptor/U-PAR antibody [EPR20191] (AB218106)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-uPA Receptor/U-PAR antibody [EPR20191] (AB218106)

Immunohistochemical analysis of paraffin-embedded human lung cancer tissue labeling uPA Receptor/U-PAR with ab218106 at 1/500 dilution followed by Goat Anti-Rabbit IgG H&L (HRP) Ready to use.

Cytoplasmic staining on the stromal cells of human lung cancer is observed [PMID : 25575713].

Counter stained with Hematoxylin.

Secondary antibody only control : Used PBS instead of primary antibody secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) Ready to use.

Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-uPA Receptor/U-PAR antibody [EPR20191] (AB218106)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-uPA Receptor/U-PAR antibody [EPR20191] (AB218106)

Immunohistochemical analysis of paraffin-embedded human ovarian cancer tissue labeling uPA Receptor/U-PAR with ab218106 at 1/500 dilution followed by Goat Anti-Rabbit IgG H&L (HRP) Ready to use.

Membranous staining on the macrophages of human ovarian cancer is observed [PMID : 25575713].

Counter stained with Hematoxylin.

Secondary antibody only control : Used PBS instead of primary antibody secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) Ready to use.

Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-uPA Receptor/U-PAR antibody [EPR20191] (AB218106)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-uPA Receptor/U-PAR antibody [EPR20191] (AB218106)

Immunohistochemical analysis of paraffin-embedded human artery tissue labeling uPA Receptor/U-PAR with ab218106 at 1/500 dilution followed by Goat Anti-Rabbit IgG H&L (HRP) Ready to use.

Positive staining on the neutrophils in human artery is observed [PMID : 25575713].

Counter stained with Hematoxylin.

Secondary antibody only control : Used PBS instead of primary antibody secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) Ready to use.

Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.

Western blot - Anti-uPA Receptor/U-PAR antibody [EPR20191] (AB218106)
  • WB

Supplier Data

Western blot - Anti-uPA Receptor/U-PAR antibody [EPR20191] (AB218106)

Blocking/Dilution buffer : 5% NFDM/TBST.

PMA-stimulated U937 cells express uPA Receptor/U-PAR in the range of 35kDa-60kDa. Non-stimulated U937 cells are negative. The deglycosylated form of the protein is at 35 kDa and the highly glycosylated protein is at 60kDa (PMID : 24999729).

All lanes:

Western blot - Anti-uPA Receptor/U-PAR antibody [EPR20191] (ab218106) at 1/1000 dilution

Lane 1:

Untreated U937 (Human histiocytic lymphoma cell line) whole cell lysate at 10 µg

Lane 2:

U937 whole cell lysate treated with 200nM PMA (Phorbol-12-myristate-13-acetate) for 72 hours at 10 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Predicted band size: 37 kDa

Observed band size: 35-65 kDa

false

Exposure time: 15s

  • Carrier free

    Anti-uPA Receptor/U-PAR antibody [EPR20191] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR20191

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

IHC-P, WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/500", "IHCP-species-notes": "<p></p>" } } }

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Acts as a receptor for urokinase plasminogen activator (PubMed : 15677461). Plays a role in localizing and promoting plasmin formation. Mediates the proteolysis-independent signal transduction activation effects of U-PA. It is subject to negative-feedback regulation by U-PA which cleaves it into an inactive form.
See full target information PLAUR

Publications (8)

Recent publications for all applications. Explore the full list and refine your search

Clinical and molecular hepatology 31:935-959 PubMed39924997

2025

Radiogenomics of intrahepatic cholangiocarcinoma predicts immunochemotherapy response and identifies therapeutic target.

Applications

Unspecified application

Species

Unspecified reactive species

Gu-Wei Ji,Zheng-Gang Xu,Shuo-Chen Liu,Shu-Ya Cao,Chen-Yu Jiao,Ming Lu,Biao Zhang,Yue Yang,Qing Xu,Xiao-Feng Wu,Ke Wang,Yong-Xiang Xia,Xiang-Cheng Li,Xue-Hao Wang

ACS omega 8:33392-33402 PubMed37744847

2023

Xuebijing Injection Attenuates Heat Stroke-Induced Brain Injury through Oxidative Stress Blockage and Parthanatos Modulation via PARP-1/AIF Signaling.

Applications

Unspecified application

Species

Unspecified reactive species

Lin Wang,Boxin Ye,Yongrui Liu,Jun Li,Chunhe Li,Minyong Wen,Hongbo Li

Cell stress & chaperones 28:253-263 PubMed37052764

2023

ENPP2 alleviates hypoxia/reoxygenation injury and ferroptosis by regulating oxidative stress and mitochondrial function in human cardiac microvascular endothelial cells.

Applications

Unspecified application

Species

Unspecified reactive species

Guanhua Fang,Yanming Shen,Dongshan Liao

Science advances 8:eabn3774 PubMed35613265

2022

Therapeutic strategies targeting uPAR potentiate anti-PD-1 efficacy in diffuse-type gastric cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Long Qin,Long Wang,Junchang Zhang,Huinian Zhou,Zhiliang Yang,Yan Wang,Weiwen Cai,Fei Wen,Xiangyan Jiang,Tiansheng Zhang,Huili Ye,Bo Long,Junjie Qin,Wengui Shi,Xiaoying Guan,Zeyuan Yu,Jing Yang,Qi Wang,Zuoyi Jiao

Frontiers in oncology 12:862723 PubMed35574375

2022

A Novel TAF-Related Signature Based on ECM Remodeling Genes Predicts Glioma Prognosis.

Applications

Unspecified application

Species

Unspecified reactive species

Lin-Jian Wang,Peipei Lv,Yongli Lou

Frontiers in oncology 11:666446 PubMed33968773

2021

Morphine Suppresses Liver Cancer Cell Tumor Properties and .

Applications

Unspecified application

Species

Unspecified reactive species

Hao-Wen Zhang,Fei Wang,Ya-Qun Zhou,San-Ping Xu,Shi-Ying Yu,Zhan-Guo Zhang

Journal of cancer research and clinical oncology 146:2189-2203 PubMed32488496

2020

Prostaglandin E2 receptor 3 (EP3) signaling promotes migration of cervical cancer via urokinase-type plasminogen activator receptor (uPAR).

Applications

Unspecified application

Species

Unspecified reactive species

Yao Ye,Lin Peng,Aurelia Vattai,Eileen Deuster,Christina Kuhn,Christian Dannecker,Sven Mahner,Udo Jeschke,Viktoria von Schönfeldt,Helene H Heidegger

Journal of experimental & clinical cancer research 38:214 PubMed31118109

2019

GPAA1 promotes gastric cancer progression via upregulation of GPI-anchored protein and enhancement of ERBB signalling pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Xiao-Xin Zhang,Bo Ni,Qing Li,Li-Peng Hu,Shu-Heng Jiang,Rong-Kun Li,Guang-Ang Tian,Li-Li Zhu,Jun Li,Xue-Li Zhang,Yan-Li Zhang,Xiao-Mei Yang,Qin Yang,Ya-Hui Wang,Chun-Chao Zhu,Zhi-Gang Zhang
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com